Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
UK regulator approves Pfizer’s hair loss drug
(Reuters) - Britain's medicines regulator on Wednesday approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease. The drug, branded as Litfulo, has been approved by UK's Medicines ...
Nov 01, 2023
Humana reaffirms 2023 profit view on strength in govt-backed plans
(Reuters) -Humana Inc reaffirmed its full-year profit forecast on Wednesday, after the health insurer beat Wall Street estimates for quarterly profit aided by a better-than-expected performance of its...
Nov 01, 2023
CVS profit beats estimates on strong performance of pharmacy operations
(Reuters) - CVS Health Corp beat Wall Street estimates for quarterly profit on Wednesday as strength in its drugstores and pharmacy benefit management business offset higher-than-expected medical cost...
Nov 01, 2023
Factbox-How Novo Nordisk makes its weight-loss drug Wegovy
By Maggie Fick LONDON (Reuters) - Novo Nordisk is spending billions of dollars to boost output and ease shortages of its hugely popular, highly effective weight-loss medicine Wegovy. The Danish drugma...
Nov 01, 2023
Indonesian court jails CEO, three others, over deadly cough syrup
JAKARTA (Reuters) - An Indonesian court sentenced to jail on Wednesday the chief executive and three other officials of a company whose cough syrup has been linked to the death of more than 200 childr...
Nov 01, 2023
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say
By Khushi Mandowara (Reuters) -Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to reach that goa...
Nov 01, 2023
AstraZeneca signs drug development deal with biotech Cellectis
(Reuters) - AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical-stage biotechnology company Cellectis to speed up the development of therapeutics i...
Nov 01, 2023
GSK raises annual forecasts powered by strong Arexvy launch
(Reuters) -GSK raised its full-year profit and sales forecasts on Wednesday for the second time this year, buoyed by the strong launch of its respiratory syncytial virus (RSV) vaccine and steady deman...
Nov 01, 2023
China kicks off nationwide population survey amid declining birth rate
HONG KONG (Reuters) - China will begin polling 1.4 million people on Wednesday in a survey on population changes, as authorities struggle to incentivise people to have more children amid a declining b...
Oct 31, 2023
Bayer ordered to pay $332 million in Roundup cancer trial -Law.com
(Reuters) -A California jury found Bayer liable in a case brought by a man who claimed his cancer was due to exposure to the company's Roundup weed killer, and ordered it to pay $332 million in damage...
Oct 31, 2023
